Females who are pregnant or nursing.
Patients not scheduled for trans-jugular liver biopsy
Patients who have received an investigational drug in the 30 days before study drug administration, or will receive one within 72 h afterwards,.
Patients with known or suspected right-to-left, bi-directional, or transient right-to-left cardiac shunts
Patients with pulmonary hypertension or unstable cardiopulmonary conditions
Patients currently on chemotherapy or with other primary cancers requiring systemic or hepatic loco-regional treatment.
Patients who are medically unstable, patients who are seriously or terminally ill, and patients whose clinical course is unpredictable. For example:
Patients on life support or in a critical care unit.
Patients with unstable occlusive disease (e.g., crescendo angina)
Patients with clinically unstable cardiac arrhythmias, such as recurrent ventricular tachycardia.
Patients with uncontrolled congestive heart failure (NYHA Class IV)
Patients with recent cerebral hemorrhage.
Patients who have undergone surgery within 24 hours prior to the study sonographic examination.
Patients with a history of anaphylactic allergy to eggs or egg products, manifested by one or more of the following symptoms: generalized urticaria, difficulty in breathing, swelling of the mouth and throat, hypotension, or shock. (Subjects with nonanaphylactic allergies to eggs or egg products may be enrolled in the study, but must be watched carefully for 1 h following the administration of SONAZOID).
Patients with congenital heart defects.
Patients with severe emphysema, pulmonary vasculitis, or a history of pulmonary emboli.
Patients with respiratory distress syndrome
Patients with thrombosis within the hepatic, portal, or mesenteric veins.

NCT02489045_exc_T1
Person
Females
NCT02489045_exc_T2
Condition
pregnant
NCT02489045_exc_T3
Condition
nursing
NCT02489045_exc_T4
Negation
not
NCT02489045_exc_T5
Mood
scheduled
NCT02489045_exc_T6
Procedure
trans-jugular liver biopsy
NCT02489045_exc_T8
Condition
transient right-to-left cardiac shunts
NCT02489045_exc_T9
Condition
directional, o diac shunts
Pa
NCT02489045_exc_T10
Condition
ht-to-left, b diac shunts
Pa
NCT02489045_exc_T11
Mood
suspected
NCT02489045_exc_T12
Mood
known
NCT02489045_exc_T13
Scope
known or suspected
NCT02489045_exc_T14
Scope
right-to-left, bi-directional, or transient right-to-left cardiac shunts
NCT02489045_exc_T15
Condition
pulmonary hypertension
NCT02489045_exc_T16
Condition
unstable cardiopulmonary conditions
NCT02489045_exc_T17
Procedure
chemotherapy
NCT02489045_exc_T18
Temporal
currently
NCT02489045_exc_T19
Procedure
hepatic loco-regional treatment
NCT02489045_exc_T20
Procedure
mic or h regional treatment.
Pat
NCT02489045_exc_T21
Condition
primary cancers
NCT02489045_exc_T22
Qualifier
other
NCT02489045_exc_T23
Scope
systemic or hepatic loco-regional treatment
NCT02489045_exc_T24
Scope
chemotherapy or with other primary cancers requiring systemic or hepatic loco-regional treatment
NCT02489045_exc_T25
Condition
medically unstable
NCT02489045_exc_T26
Condition
sly or te nd
NCT02489045_exc_T27
Condition
terminally ill
NCT02489045_exc_T28
Condition
clinical course is unpredictable
NCT02489045_exc_T29
Procedure
life support
NCT02489045_exc_T30
Visit
critical care unit
NCT02489045_exc_T31
Condition
unstable occlusive disease
NCT02489045_exc_T32
Scope
crescendo angina
NCT02489045_exc_T33
Qualifier
clinically unstable
NCT02489045_exc_T34
Condition
cardiac arrhythmias
NCT02489045_exc_T35
Condition
ventricular tachycardia
NCT02489045_exc_T36
Multiplier
recurrent
NCT02489045_exc_T37
Scope
clinically unstable cardiac arrhythmias
NCT02489045_exc_T38
Qualifier
uncontrolled
NCT02489045_exc_T39
Condition
congestive heart failure
NCT02489045_exc_T40
Measurement
NYHA
NCT02489045_exc_T41
Value
Class IV
NCT02489045_exc_T42
Scope
uncontrolled congestive heart failure
NCT02489045_exc_T43
Temporal
recent
NCT02489045_exc_T44
Condition
cerebral hemorrhage
NCT02489045_exc_T45
Procedure
surgery
NCT02489045_exc_T46
Temporal
within 24 hours prior to the study sonographic examination
NCT02489045_exc_T47
Reference_point
the study sonographic examination
NCT02489045_exc_T48
Procedure
sonographic examination
NCT02489045_exc_T49
Condition
anaphylactic allergy
NCT02489045_exc_T50
Drug
eggs
NCT02489045_exc_T51
Drug
egg products
NCT02489045_exc_T52
Scope
eggs or egg products
NCT02489045_exc_T53
Condition
generalized urticaria
NCT02489045_exc_T54
Condition
difficulty in breathing
NCT02489045_exc_T55
Condition
swelling of the mouth
NCT02489045_exc_T56
Condition
he mouth and th ension
NCT02489045_exc_T57
Condition
hypotension
NCT02489045_exc_T58
Condition
shock
NCT02489045_exc_T59
Scope
generalized urticaria, difficulty in breathing, swelling of the mouth and throat, hypotension, or shock
NCT02489045_exc_T60
Scope
anaphylactic allergy to eggs or egg products
NCT02489045_exc_T61
Condition
congenital heart defects
NCT02489045_exc_T62
Qualifier
severe
NCT02489045_exc_T63
Condition
emphysema
NCT02489045_exc_T64
Condition
pulmonary vasculitis
NCT02489045_exc_T65
Condition
pulmonary emboli
NCT02489045_exc_T66
Condition
respiratory distress syndrome
NCT02489045_exc_T67
Condition
thrombosis
NCT02489045_exc_T68
Qualifier
mesenteric veins
NCT02489045_exc_T69
Qualifier
eric v
NCT02489045_exc_T70
Qualifier
or mese
NCT02489045_exc_T71
Scope
hepatic, portal, or mesenteric veins